The 100-Index of the Pakistan Stock Exchange (PSX) witnessed bullish trend on Monday, gaining 1,055.03 points, a positive ...

FIBRONEER™-ILD was a double-blind, randomized, placebo-controlled trial evaluating the efficacy and safety of nerandomilast ...

IVIEW Therapeutics Inc., a clinical-stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, today announced positive topline data from its Phase 1/2 clinical ...

Bulls took over the trading floor at the Pakistan Stock Exchange (PSX) as shares climbed more than 1,000 points on Monday after a week of persistent institutional selling. The benchmark KSE-100 index ...

We are targeting 5x growth in pipes and fittings by 2026 and 83% YoY growth in the PVC pipes business driven by Tier II and ...

The company’s revenue in the third quarter rose to ₹1,695 crore, growing almost 31 per cent from ₹1,296 crore a year earlier, ...

Axalta continues to exceed expectations, with potential upside ahead. Read why AXTA stock could perform well as it meets its ...

Blue Bird experienced a slight topline contraction due to a decrease in EV share in total volumes during Q1. See why I rate ...

Grasim Industries is expected to report a 23-30% YoY rise in its December quarter revenue, ranging from Rs 7,852 crore to Rs ...

Ritesh Agarwal-led OYO posts significant growth in all major financial figures for the third quarter in a period that saw major international acquisitions, according to Agencies ...

The company's revenue in the third quarter rose to Rs 1,695 crore, growing almost 31 per cent from Rs 1,296 crore a year ...

Travel tech unicorn OYO recorded a profit after tax (PAT) of ₹166 crore in the third quarter ended December, up nearly six ...